Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 15.54 -1.02% -0.16
CARA closed down 1.02 percent on Wednesday, December 12, 2018, on 85 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CARA trend table...

Date Alert Name Type % Chg
Dec 12 NR7 Range Contraction 0.00%
Dec 12 Lower Bollinger Band Walk Weakness 0.00%
Dec 12 Below Lower BB Weakness 0.00%
Dec 12 Down 3 Days in a Row Weakness 0.00%
Dec 12 Down 4 Days in a Row Weakness 0.00%
Dec 12 Down 5 Days in a Row Weakness 0.00%
Dec 12 Lower Bollinger Band Touch Weakness 0.00%
Dec 12 Oversold Stochastic Weakness 0.00%
Dec 11 Lower Bollinger Band Walk Weakness -1.02%
Dec 11 Inside Day Range Contraction -1.02%

Older signals for CARA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Is CARA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.3
52 Week Low 11.46
Average Volume 543,182
200-Day Moving Average 17.1463
50-Day Moving Average 18.9244
20-Day Moving Average 17.834
10-Day Moving Average 17.205
Average True Range 0.9135
ADX 35.43
+DI 8.1423
-DI 29.4608
Chandelier Exit (Long, 3 ATRs ) 17.5995
Chandelier Exit (Short, 3 ATRs ) 18.1305
Upper Bollinger Band 20.0747
Lower Bollinger Band 15.5933
Percent B (%b) -0.01
BandWidth 25.128406
MACD Line -0.8773
MACD Signal Line -0.6017
MACD Histogram -0.2756
Fundamentals Value
Market Cap 506.3 Million
Num Shares 32.6 Million
EPS -2.28
Price-to-Earnings (P/E) Ratio -6.82
Price-to-Sales 424.16
Price-to-Book 3.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.35
Resistance 3 (R3) 16.41 16.21 16.22
Resistance 2 (R2) 16.21 16.00 16.18 16.17
Resistance 1 (R1) 15.87 15.87 15.77 15.81 16.12
Pivot Point 15.67 15.67 15.62 15.64 15.67
Support 1 (S1) 15.33 15.46 15.23 15.27 14.96
Support 2 (S2) 15.13 15.33 15.10 14.91
Support 3 (S3) 14.79 15.13 14.87
Support 4 (S4) 14.73